Future Medicine Ltd., part of Future Science Group, UK, has announced a new partnership between the Personalized Medicine Coalition (PMC) and the journal Personalized Medicine, for 2008. The journal addresses scientific, commercial and policy issues in personalised medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles. In addition to the regular features, the 2008 volume will include news and views from the PMC. An article will be selected from each issue to feature on the Coalition's website.
Members of the PMC have always been well represented within the editorial team and advisory panel of the journal, and also amongst the contributors. Full articles published in Personalized Medicine are subject to independent review by a minimum of three independent experts and the journal offers rapid publication, aiming to publish within 8-10 weeks of original submission, with fast track options available.
Published bimonthly, Personalized Medicine translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organisations and others in the healthcare community. The journal assists these parties to shape the future of medicine by providing a platform for expert commentary and analysis.
More News in this Theme
